APA

Hsu F., Liu Y., Chiang I., Liu R., Wang H., Lin W. & Hwang J. (20150115). Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. : International journal of oncology.

Chicago

Hsu Fei-Ting, Liu Yu-Chang, Chiang I-Tsang, Liu Ren-Shyan, Wang Hsin-Ell, Lin Wuu-Jyh and Hwang Jeng-Jong. 20150115. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. : International journal of oncology.

Harvard

Hsu F., Liu Y., Chiang I., Liu R., Wang H., Lin W. and Hwang J. (20150115). Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. : International journal of oncology.

MLA

Hsu Fei-Ting, Liu Yu-Chang, Chiang I-Tsang, Liu Ren-Shyan, Wang Hsin-Ell, Lin Wuu-Jyh and Hwang Jeng-Jong. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. : International journal of oncology. 20150115.